The Hill :press: on Nostr: Defending the Bayh-Dole Act, or why governments shouldn't dictate the cost of drugs ...
Published at
2024-04-13 20:24:05Event JSON
{
"id": "56d73e489b1b8ab42322127da9ddc62706c7853a384198bac47b6fcbee5ccefe",
"pubkey": "60aa31f16e38c785647c438db3391846c4d92f53712b6968d9bfc01ca644c061",
"created_at": 1713039845,
"kind": 1,
"tags": [
[
"t",
"press"
],
[
"proxy",
"https://press.coop/users/thehill/statuses/112265779287495035",
"activitypub"
]
],
"content": "Defending the Bayh-Dole Act, or why governments shouldn't dictate the cost of drugs \n\nInnovators in the U.S. must maintain their intellectual property rights if they are to provide the returns expected by current and future investors. #press\n\nhttps://thehill.com/opinion/healthcare/4591393-defending-the-bayh-dole-act-or-why-governments-shouldnt-dictate-the-cost-of-drugs/?utm_source=press.coop\n\nhttps://thehill.com/wp-content/uploads/sites/2/2023/03/GettyImages-1434708636.jpg?w=900",
"sig": "2c3db56e8e2b44ceb750ce2ba7b1242c21875b1e554da5f285aa55a9f01f2524056d4bc1eb8107e5c5746c794dd828b5b3df183c7e53cc9b2cac1bbc0aeee2d4"
}